This page is archived

Links to external sources may no longer work as intended. The content may not represent the latest thinking in this area or the Society’s current position on the topic.

DNA deamination in immunity, virology and cancer

09 - 10 June 2008

By Dr P J Gearhart, Dr Tomas Lindahl and Professor Michael Neuberger FRS

DNA deamination (used to generate antibody diversity) is the only known programme in mammalian development in which the coding capacity of the genome is changed by targeted modification of one of the DNA bases. The same process, however, is used to attack lentiviruses (eg HIV). This meeting will bring together interested immunologists, virologists, cancer scientists and DNA repair biochemists.